摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-(5-((pyridin-4-ylamino)methyl)furan-2-yl)-1H-benzo[d]imidazol-1-yl)acetohydrazide

中文名称
——
中文别名
——
英文名称
2-(2-(5-((pyridin-4-ylamino)methyl)furan-2-yl)-1H-benzo[d]imidazol-1-yl)acetohydrazide
英文别名
2-[2-[5-[(Pyridin-4-ylamino)methyl]furan-2-yl]benzimidazol-1-yl]acetohydrazide;2-[2-[5-[(pyridin-4-ylamino)methyl]furan-2-yl]benzimidazol-1-yl]acetohydrazide
2-(2-(5-((pyridin-4-ylamino)methyl)furan-2-yl)-1H-benzo[d]imidazol-1-yl)acetohydrazide化学式
CAS
——
化学式
C19H18N6O2
mdl
——
分子量
362.391
InChiKey
GRGQKPUSPPAJKE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    111
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    麦穗宁盐酸 、 hydrazine hydrate 、 potassium carbonate 作用下, 以 乙醇丙酮 为溶剂, 反应 7.0h, 生成 2-(2-(5-((pyridin-4-ylamino)methyl)furan-2-yl)-1H-benzo[d]imidazol-1-yl)acetohydrazide
    参考文献:
    名称:
    Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents
    摘要:
    2-(2-Furyl)-1H-benzimidazoles 3-11 were synthesized and tested for their in vitro VEGF inhibition in MCF-7 cancer cell line. Compound 5a was more potent than Tamoxifen, and compounds 3b, 5a, 5c, 6b, 7a and 10 showed promising potency. Furthermore, compounds (6b, 7a and 10) showed remarkable selective inhibition of COX-2 enzyme close to that of Celecoxcib. Additionally, docking studies were performed using AutoDock 4.2 into the VEGFR2 kinase. Significant correlation exists between the biological activity (IC50 and %VEGF inhibition) against MCF-7 cell line and the molecular docking results (K-i and Delta G(b)) with correlation coefficients (R-2) of 0.5513 and 0.4623 respectively. Accordingly, most of the synthesized 2-(2-furyl)-1H-benzimidazoles showed strong antiangiogenic activity against VEGFR2 kinase. (c) 2014 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2014.01.063
点击查看最新优质反应信息

文献信息

  • Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents
    作者:Ahmed Temirak、Yasser M. Shaker、Fatma A.F. Ragab、Mamdouh M. Ali、Hamed I. Ali、Hoda I. El Diwani
    DOI:10.1016/j.ejmech.2014.01.063
    日期:2014.11
    2-(2-Furyl)-1H-benzimidazoles 3-11 were synthesized and tested for their in vitro VEGF inhibition in MCF-7 cancer cell line. Compound 5a was more potent than Tamoxifen, and compounds 3b, 5a, 5c, 6b, 7a and 10 showed promising potency. Furthermore, compounds (6b, 7a and 10) showed remarkable selective inhibition of COX-2 enzyme close to that of Celecoxcib. Additionally, docking studies were performed using AutoDock 4.2 into the VEGFR2 kinase. Significant correlation exists between the biological activity (IC50 and %VEGF inhibition) against MCF-7 cell line and the molecular docking results (K-i and Delta G(b)) with correlation coefficients (R-2) of 0.5513 and 0.4623 respectively. Accordingly, most of the synthesized 2-(2-furyl)-1H-benzimidazoles showed strong antiangiogenic activity against VEGFR2 kinase. (c) 2014 Elsevier Masson SAS. All rights reserved.
查看更多